SINOVAC BIOTECH LTD Cash and Restricted Cash
SINOVAC BIOTECH LTD (SVA) had Cash and Restricted Cash of $1.16 billion as of 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-06-05
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.16B.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $602.22M.
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.13B; Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed $1.28B.
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.89B; Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed $4.29B.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2025-12-31 | $1.16B 20-F · filed 2026-06-05 | |
| 2024-12-31 | $602.22M 20-F · filed 2026-06-05 | |
| 2023-12-31 | $1.13B 20-F · filed 2026-06-05 | $1.28B 20-F · filed 2024-04-29 |
| 2022-12-31 | $3.89B 20-F · filed 2026-06-05 | $4.29B 20-F · filed 2023-05-01 |
| 2021-12-31 | $11.62B 20-F · filed 2026-04-30 | |
| 2020-12-31 | $1.05B 20-F · filed 2026-04-30 | |
| 2019-12-31 | $155.88M 20-F · filed 2023-05-01 | |
| 2018-12-31 | $158.17M 20-F · filed 2022-04-29 | |
| 2017-12-31 | $115.96M 20-F · filed 2021-04-22 | |
| 2016-12-31 | $65.44M 20-F · filed 2020-04-30 | |
| 2015-12-31 | $65.46M 20-F · filed 2019-04-29 |